Search Orphan Drug Designations and Approvals
-
Generic Name: | recombinant human lecithin:cholesterol acyltransferase (rhLCAT) |
---|---|
Date Designated: | 09/02/2010 |
Orphan Designation: | Treatment of familial lecithin-cholesterol acyltransferase deficiency (FLD). |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
MedImmune 1 Medimmune Way Gaithersburg, Maryland 20878 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-